Conclusion

por Cortes-Funes, H
Publicado 2003

The role of Xeloda in metastasic breast cancer

por Cortés-Funes, H
Publicado 2005

Extensive experience of disease control with gefitinib and the role of prognostic markers

por Cortes-Funes, H, Soto Parra, H
Publicado 2003

Management of metastatic breast cancer: are we prepared to cope with our own success?

por Jimeno, A, Cortés-Funes, H, Colomer, R
Publicado 2004

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer

por Cortés-Funes, H, Mendiola, C, Manso, L, Ciruelos, E
Publicado 2009

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab

por Manso, L, Ciruelos, E, Rodríguez, A, Diaz, J, Mendiola, C, López-Martín, JA, Cortes-Funes, H
Publicado 2009

Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response

por Reyes, E, García-Castro, I, Esquivel, F, Hornedo, J, Cortes-Funes, H, Solovera, J, Alvarez-Mon, M
Publicado 1999

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value

por Ciruelos, E, Castaneda, C, Pascual, T, Andrés, E, Gomez, HL, Manso, L, Valdivieso, N, Ghanem, I, Cortes-Funes, H
Publicado 2011

Lobular carcinoma of the breast: outcome of 205 patients

por Vega, E, Ciruelos, E, Valdiviezo, N, Mendiola, C, Manso, L, Ghanem, I, Dorta, M, Pascual, T, Flores, C, Cortés-Funes, H
Publicado 2011

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in...

por Ciruelos, EM, López-Vivanco, G, Peláez, I, Rifa, J, Santaballa, A, González, S, Segui, MA, Jara, C, Alvarez, I, Cortés-Funes, H
Publicado 2009

Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

por Hitt, R, Jimeno, A, Rodríguez-Pinilla, M, Rodríguez-Peralto, J L, Millán, J M, López-Martín, A, Brandariz, A, Peña, C, Cortés-Funes, H
Publicado 2004

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracy...

por Campone, M, Cortes-Funes, H, Vorobiof, D, Martin, M, Slabber, C F, Ciruelos, E, Bourbouloux, E, Mendiola, C, Delgado, F M, Colin, C, Aslanis, V, Fumoleau, P
Publicado 2006

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

por Yap, T A, Cortes-Funes, H, Shaw, H, Rodriguez, R, Olmos, D, Lal, R, Fong, P C, Tan, D S, Harris, D, Capdevila, J, Coronado, C, Alfaro, V, Soto-Matos, A, Fernández-Teruel, C, Siguero, M, Tabernero, J M, Paz-Ares, L, de Bono, J S, López-Martin, J A
Publicado 2012